Another notable finding was that APOE ɛ4 predicted slope but not level of cognitive performance in this study group, and that the effect on slope was only seen when including the last test occasion where the probability of individuals being at a preclinical stage of Alzheimer’s disease was higher. The gene discussed is APOE; the disease is Alzheimer disease.